Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Return on Equity (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Return on Equity for 6 consecutive years, with 5.62% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 365.0% to 5.62% in Q3 2025 year-over-year; TTM through Sep 2025 was 5.62%, a 365.0% decrease, with the full-year FY2024 number at 5.25%, down 998.0% from a year prior.
  • Return on Equity was 5.62% for Q3 2025 at Ensysce Biosciences, down from 2.31% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 10.49% in Q1 2023 to a low of 196.85% in Q2 2022.
  • A 5-year average of 13.31% and a median of 2.15% in 2025 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: tumbled -20153bps in 2022, then surged 18741bps in 2023.
  • Ensysce Biosciences' Return on Equity stood at 5.16% in 2021, then decreased by -10bps to 4.63% in 2022, then plummeted by -1045bps to 43.73% in 2023, then surged by 96bps to 1.56% in 2024, then tumbled by -261bps to 5.62% in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Return on Equity are 5.62% (Q3 2025), 2.31% (Q2 2025), and 2.15% (Q1 2025).